Please assess the completion status of the following clinical trial:

Trial Title: Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Iron deficiency anemia intolerant of or failure to respond to oral iron or condition where oral iron is known to be ineffective or harmful.~* Subject must be able to be contacted at 24-48 hours after dose and come for followup at four weeks.~* Subject must be capable of understanding informed consent~* No other form of iron may be taken within four weeks of consent or for four weeks after treatment~Exclusion Criteria:~* History of hypersensitivity to ferumoxytol.~* Imminent dialysis.~* Anemia due to other etiology.~* Parenteral iron within 4 weeks of consent.~* Pregnancy.~* Erythropoiesis stimulating agent within 30 days of consent.~* Other illness that would interfere with participation or understanding of trial.~* Major surgery planned within four weeks of consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- ferumoxytol (Type: OTHER): IV administration of 1020 mg of ferumoxytol in 15 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).